Literature DB >> 1660881

Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A.

Y F Liu1, P R Albert.   

Abstract

Heterologous expression of the rat 5-HT1A receptor in stably transfected GH4C1 rat pituitary cells (clone GH4ZD10) and mouse Ltk- fibroblast cells (clone LZD-7) (Albert, P.R., Zhou, Q.-Y., VanTol, H.H.M., Bunzow, J.R., and Civelli, O. (1990) J. Biol. Chem. 265, 5825-5832) was used to characterize the cellular specificity of signal transduction by the 5-HT1A receptor. We demonstrate that the 5-HT1A receptor, acting via pertussis toxin-sensitive G proteins, can change its inhibitory signaling phenotype and become a stimulatory receptor, depending on the cell type, differentiation state, or intracellular milieu of the cell in which it is expressed. When expressed in pituitary GH4ZD10 cells, activation of 5-HT1A receptors decreased both basal and vasoactive intestinal peptide-enhanced cAMP accumulation and blocked (+/-)-Bay K8644-induced influx of calcium, inhibitory responses which are typical of neurons which endogenously express this receptor. Similarly, 5-hydroxytryptamine (5-HT) also inhibited adenylyl cyclase in fibroblast LZD-7 cells, reducing the forskolin-induced enhancement of cAMP levels by 50%, but did not alter basal cAMP levels. In contrast to GH4ZD10 cells, where 5-HT had no effect on basal or thyrotropin-releasing hormone-induced phosphatidylinositol turnover, 5-HT enhanced the accumulation of inositol phosphates and induced a biphasic increase in [Ca2+]i in LZD-7 cells. These dominant stimulatory actions of 5-HT, as well as the inhibitory effects, were absent in untransfected cells and displayed the potency and pharmacological specificity of the 5-HT1A receptor, indicating that the 5-HT1A subtype coupled to both inhibitory and stimulatory pathways in the fibroblast cell. The actions of 5-HT in GH and L cells were blocked by 24-h pretreatment with pertussis toxin, suggesting that inhibitory G proteins (Gi/G(o)) mediate both inhibitory and stimulatory signal transduction of the 5-HT1A receptor. However, the 5-HT-induced stimulatory pathway in fibroblasts was blocked selectively by acute (2-min) pretreatment with TPA, an activator of protein kinase C. This action of protein kinase C was potentiated by activation of protein kinase A, indicating that the expression of the stimulatory pathway of the 5-HT1A receptor in LZD-7 cells is modulated by second messengers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660881

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells.

Authors:  Thierry Wurch; Petrus J Pauwels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-16       Impact factor: 3.000

3.  Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress.

Authors:  Manas R Biswal; Chulbul M Ahmed; Cristhian J Ildefonso; Pingyang Han; Hong Li; Hiral Jivanji; Haoyu Mao; Alfred S Lewin
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

Review 4.  5-HT1A receptor-regulated signal transduction pathways in brain.

Authors:  Abigail M Polter; Xiaohua Li
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

5.  Potent depression of stimulus evoked field potential responses in the medial entorhinal cortex by serotonin.

Authors:  D Schmitz; T Gloveli; R M Empson; U Heinemann
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.

Authors:  T Jolas; S Haj-Dahmane; L Lanfumey; C M Fattaccini; E J Kidd; J Adrien; H Gozlan; B Guardiola-Lemaitre; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

7.  Differential coupling of the formyl peptide receptor to adenylate cyclase and phospholipase C by the pertussis toxin-insensitive Gz protein.

Authors:  R C Tsu; H W Lai; R A Allen; Y H Wong
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

8.  GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.

Authors:  C J Fowler; P C Ahlgren; G Brännström
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets.

Authors:  M L Trincavelli; S Cuboni; M Montali; S Santaguida; A Lucacchini; C Martini
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

10.  Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation.

Authors:  Chiung-Wen Chang; Ethan Poteet; John A Schetz; Zeynep H Gümüş; Harel Weinstein
Journal:  Neuropharmacology       Date:  2008-08-13       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.